REPORT ID 2117

Asia-Pacific PDE Inhibitors Market Report 2017

Publish Date
7-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the Asia-Pacific PDE Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (), revenue (Million USD), market share and growth rate of PDE Inhibitors for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific PDE Inhibitors market competition by top manufacturers/players, with PDE Inhibitors sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Hanmi Science Holding
    Boehringer Ingelheim
    Takeda Pharmaceuticals
    Pfizer
    Omeros
    Anacor Pharmaceuticals
    Otsuka
    Chiesi Farmaceutici
    Verona Pharma
    NuSirt Biopharma

On the basis of product, this report displays the sales volume (), revenue (Million USD), product price (), market share and growth rate of each type, primarily split into
    PDE5
    PDE4
    Viagra
    Cialis
    Levitra
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (), market share and growth rate of PDE Inhibitors for each application, includin
    GENITOURINARY
    CARDIOVASCULAR DISEASES
    NEUROLOGICAL DISEASES
    DERMATOLOGICAL DISORDERS
    RESPIRATORY DISEASES
    OTHER INDICATIONS

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific PDE Inhibitors Market Report 2017
1 PDE Inhibitors Overview
    1.1 Product Overview and Scope of PDE Inhibitors
    1.2 Classification of PDE Inhibitors by Product Category
        1.2.1 Asia-Pacific PDE Inhibitors Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific PDE Inhibitors Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 PDE5
        1.2.4 PDE4
        1.2.5 Viagra
        1.2.6 Cialis
        1.2.7 Levitra
        1.2.8 Others
    1.3 Asia-Pacific PDE Inhibitors Market by Application/End Users
        1.3.1 Asia-Pacific PDE Inhibitors Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 GENITOURINARY
        1.3.3 CARDIOVASCULAR DISEASES
        1.3.4 NEUROLOGICAL DISEASES
        1.3.5 DERMATOLOGICAL DISORDERS
        1.3.6 RESPIRATORY DISEASES
        1.3.7 OTHER INDICATIONS
    1.4 Asia-Pacific PDE Inhibitors Market by Region
        1.4.1 Asia-Pacific PDE Inhibitors Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of PDE Inhibitors (2012-2022)
        1.5.1 Asia-Pacific PDE Inhibitors Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific PDE Inhibitors Revenue and Growth Rate (2012-2022)

2 Asia-Pacific PDE Inhibitors Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific PDE Inhibitors Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific PDE Inhibitors Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific PDE Inhibitors Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific PDE Inhibitors (Volume and Value) by Type
        2.2.1 Asia-Pacific PDE Inhibitors Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific PDE Inhibitors Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific PDE Inhibitors (Volume) by Application
    2.4 Asia-Pacific PDE Inhibitors (Volume and Value) by Region
        2.4.1 Asia-Pacific PDE Inhibitors Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific PDE Inhibitors Revenue and Market Share by Region (2012-2017)

3 China PDE Inhibitors (Volume, Value and Sales Price)
    3.1 China PDE Inhibitors Sales and Value (2012-2017)
        3.1.1 China PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
        3.1.2 China PDE Inhibitors Revenue and Growth Rate (2012-2017)
        3.1.3 China PDE Inhibitors Sales Price Trend (2012-2017)
    3.2 China PDE Inhibitors Sales Volume and Market Share by Type
    3.3 China PDE Inhibitors Sales Volume and Market Share by Application

4 Japan PDE Inhibitors (Volume, Value and Sales Price)
    4.1 Japan PDE Inhibitors Sales and Value (2012-2017)
        4.1.1 Japan PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan PDE Inhibitors Revenue and Growth Rate (2012-2017)
        4.1.3 Japan PDE Inhibitors Sales Price Trend (2012-2017)
    4.2 Japan PDE Inhibitors Sales Volume and Market Share by Type
    4.3 Japan PDE Inhibitors Sales Volume and Market Share by Application

5 South Korea PDE Inhibitors (Volume, Value and Sales Price)
    5.1 South Korea PDE Inhibitors Sales and Value (2012-2017)
        5.1.1 South Korea PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea PDE Inhibitors Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea PDE Inhibitors Sales Price Trend (2012-2017)
    5.2 South Korea PDE Inhibitors Sales Volume and Market Share by Type
    5.3 South Korea PDE Inhibitors Sales Volume and Market Share by Application

6 Taiwan PDE Inhibitors (Volume, Value and Sales Price)
    6.1 Taiwan PDE Inhibitors Sales and Value (2012-2017)
        6.1.1 Taiwan PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan PDE Inhibitors Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan PDE Inhibitors Sales Price Trend (2012-2017)
    6.2 Taiwan PDE Inhibitors Sales Volume and Market Share by Type
    6.3 Taiwan PDE Inhibitors Sales Volume and Market Share by Application

7 India PDE Inhibitors (Volume, Value and Sales Price)
    7.1 India PDE Inhibitors Sales and Value (2012-2017)
        7.1.1 India PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
        7.1.2 India PDE Inhibitors Revenue and Growth Rate (2012-2017)
        7.1.3 India PDE Inhibitors Sales Price Trend (2012-2017)
    7.2 India PDE Inhibitors Sales Volume and Market Share by Type
    7.3 India PDE Inhibitors Sales Volume and Market Share by Application

8 Southeast Asia PDE Inhibitors (Volume, Value and Sales Price)
    8.1 Southeast Asia PDE Inhibitors Sales and Value (2012-2017)
        8.1.1 Southeast Asia PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia PDE Inhibitors Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia PDE Inhibitors Sales Price Trend (2012-2017)
    8.2 Southeast Asia PDE Inhibitors Sales Volume and Market Share by Type
    8.3 Southeast Asia PDE Inhibitors Sales Volume and Market Share by Application

9 Australia PDE Inhibitors (Volume, Value and Sales Price)
    9.1 Australia PDE Inhibitors Sales and Value (2012-2017)
        9.1.1 Australia PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia PDE Inhibitors Revenue and Growth Rate (2012-2017)
        9.1.3 Australia PDE Inhibitors Sales Price Trend (2012-2017)
    9.2 Australia PDE Inhibitors Sales Volume and Market Share by Type
    9.3 Australia PDE Inhibitors Sales Volume and Market Share by Application

10 Asia-Pacific PDE Inhibitors Players/Suppliers Profiles and Sales Data
    10.1 Hanmi Science Holding
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 PDE Inhibitors Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Boehringer Ingelheim
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 PDE Inhibitors Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Takeda Pharmaceuticals
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 PDE Inhibitors Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Pfizer
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 PDE Inhibitors Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Pfizer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Omeros
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 PDE Inhibitors Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Omeros PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Anacor Pharmaceuticals
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 PDE Inhibitors Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Anacor Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Otsuka
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 PDE Inhibitors Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Otsuka PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Chiesi Farmaceutici
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 PDE Inhibitors Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Verona Pharma
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 PDE Inhibitors Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Verona Pharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 NuSirt Biopharma
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 PDE Inhibitors Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview

11 PDE Inhibitors Manufacturing Cost Analysis
    11.1 PDE Inhibitors Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of PDE Inhibitors

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 PDE Inhibitors Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of PDE Inhibitors Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific PDE Inhibitors Market Forecast (2017-2022)
    15.1 Asia-Pacific PDE Inhibitors Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific PDE Inhibitors Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific PDE Inhibitors Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific PDE Inhibitors Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific PDE Inhibitors Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific PDE Inhibitors Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific PDE Inhibitors Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China PDE Inhibitors Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan PDE Inhibitors Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea PDE Inhibitors Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan PDE Inhibitors Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India PDE Inhibitors Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia PDE Inhibitors Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia PDE Inhibitors Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific PDE Inhibitors Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific PDE Inhibitors Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific PDE Inhibitors Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific PDE Inhibitors Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific PDE Inhibitors Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer